Norbert Kiss
President and Chief Executive OfficerCircularity Healthcare LLC
Member Since May 2019
About
I'm the CEO at the emerging global biotech Circularity Healthcare (D'OXYVA) and am an entrepreneur, investor, and inventor, a lifetime-learner. With 25 years of diverse experience in 60 countries, I've negotiated acquisition transactions, developed & implemented unique business models, economic & technical feasibility studies, IP protection & monetization strategies, and business plans for a range of early-stage and emerging companies & technologies in such fields as life & material sciences, conventional & green energy, water & wastewater, transportation, and commercial real estate valued at several hundred thousand to several billion dollars. I'm passionate about providing innovative pragmatic solutions with an entrepreneurial creative leadership approach having a track record of improving productivity and promoting shareholder value via diverse experiences in general management, business development, strategic planning, turnarounds, and start-ups at home in the States and internationally. I'm affiliated & working with think & do tanks, private & institutional investor groups, high net worth individuals, and people having such achievements as Live Aid, 84’ LA Summer Olympics, and Centrum Multivitamin. I received my formal & private education and gained extensive entrepreneurial and executive business experience in the U.S., Europe, and Asia in such fields as sales and marketing, business development, administration, and management, asset management, and macroeconomics. I devote my time to family, playing sports, and learning diverse interdisciplinary topics in science, business, politics, economics, and the law.
Norbert Kiss
Published content
article
You have to be able to maximize shareholder value without compromising the mission and ethical and moral values of your organization.
Company details
Circularity Healthcare LLC
Company bio
Circularity Healthcare is an emerging biotech world leader in proprietary circulatory health and noninvasive drug delivery technologies. We are committed to radically changing the standard of care and improving lives. Makers of D'OXYVA® (deoxyhemoglobin vasodilator) is the first of its kind biotech solution. D'OXYVA has been clinically validated for a variety of significant and rare health, athletic, and cosmetic benefits with record time and cost savings.